… . More than 20 Indian drugmakers, including Sun Pharma, Dr Reddy’s, Cipla … portfolio shifts Alongside obesity drugs, pharmaceutical companies are increasing AI-led … convergence of AI and digital technologies and personalised medicine will accelerate …

… wholly owned subsidiary, Ola Electric Technologies (OET), has approved the allotment … future business expansion. Ajanta Pharma: The drugmaker has entered into an in … its tobacco leaf inventory. Endurance Technologies: A cybersecurity incident occurred on …

The pharmaceutical industry is pushing back against the government’s proposed drug pricing overhaul. The industry called for an “overall reexamination” of the plan, insisting it threatens the domestic pharmaceutical sector’s profit structure, R&D …

Roche Diagnostics ups Johnny Smith to global communications head April 2 Johnny Smith secured the top healthcare people move of the year spot among PRWeek readers in 2025. Smith, who previously served as VP of commercial enablement for Roche Diagnostics …

… drugmakers. In the first ten months of 2025, Chinese pharmaceutical … Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use … domestically developed solutions to critical technological bottlenecks, providing early engagement …

… , December 27 (IANS): Hyderabad-based drugmaker Indian Immunologicals Limited (IIL) on … . Earlier this week, the Australian Technical Advisory Group on Immunisation issued … stakeholders that the company’s pharmacovigilance and quality systems are robust …

… onward, industry leaders said. In pharmaceuticals, the year brought together several … and next-generation therapies. Indian drugmakers have already started adjusting through … pressures on exports. Multinational health-tech companies also see momentum building …

… on the U.S. Big Tech, Trump tariffs, sticky inflation … parts of the broader tech sector faced volatility, chipmakers … favors financial ETFs. Pharma iShares U.S. Pharmaceuticals ETF IHE – … “super-cycle,” with major drugmakers committing about $370 billion to …

… certain products, such as steel, pharmaceuticals, and energy commodities. Many countries … of current recipients employed in technology-related positions. The executive … funding, targeted subsidies for generic drugmakers, and flexible mechanisms to prevent …

Dynavax Technologies Corporation experienced a dramatic surge … following the announcement that French pharmaceutical giant Sanofi has agreed to … U.S.-based rare disease drugmaker BluePrint Medicines. Thomas Triomphe, Executive …